首页> 外文OA文献 >PND4 GLATIRAMER ACETATE VERSUS INTERFERON BETA-1B FOR SUBCUTANEOUS ADMINISTRATION: A COMPARISON OF OUTCOMES AMONG MULTIPLE SCLEROSIS PATIENTS

【2h】

PND4 GLATIRAMER ACETATE VERSUS INTERFERON BETA-1B FOR SUBCUTANEOUS ADMINISTRATION: A COMPARISON OF OUTCOMES AMONG MULTIPLE SCLEROSIS PATIENTS

机译：皮下注射PND4醋酸格拉默对干扰素BETA-1B：多发性硬化症患者治疗效果的比较

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Castelli-Haley J; Oleen-Burkey M; Lage MJ; Johnson K;
展开▼
作者单位

展开▼
年度 2008
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Glatiramer acetate versus interferon beta-1a for subcutaneous administration: Comparison of outcomes among multiple sclerosis patients. [J] . Castelli-Haley J, Oleen-Burkey MK, Lage MJ, Advances in therapy. . 2008,第7期

机译：醋酸格拉替雷与干扰素β-1a的皮下给药：多发性硬化症患者预后的比较。
2. Glatiramer acetate versus interferon Beta-1a for subcutaneous administration: Comparison of outcomes among multiple sclerosis patients [J] . Jane Castelli-Haley, MerryKay A. Oleen-Burkey, Maureen J. Lage, Advances in Therapy . 2008,第8期

机译：醋酸格拉替雷与干扰素β-1a皮下给药：多发性硬化症患者的预后比较
3. Glatiramer acetate versus interferon beta-1a for subcutaneous administration: Comparison of outcomes among multiple sclerosis patients [J] . Jane Castelli-Haley, Merry-Kay A. Oleen-Burkey, Maureen J. Lage, Advances in Therapy . 2008,第7期

机译：醋酸格拉替雷与干扰素β-1a皮下给药：多发性硬化症患者预后的比较
4. Comparison of Glatiramer Acetate Through Differential Mass Spectrometry [C] . Sarah M. Rogstad, Eric Pang, Cynthia Sommers, ASMS Conference on Mass Spectrometry and Allied Topics . 2015

机译：通过差分质谱比较醋酸乙醇酸酯的比较
5. Comparison between specialty pharmacy care and usual pharmacy care on health outcomes and costs among multiple sclerosis patients. [D] . Tang, Jun. 2012

机译：多发性硬化症患者中专业药房护理和常规药房护理对健康结局和费用的比较。
6. Impact of a switch to fingolimod versus staying on glatiramer acetate or beta interferons on patient- and physician-reported outcomes in relapsing multiple sclerosis: post hoc analyses of the EPOC trial [O] . Jonathan Calkwood, Bruce Cree, Heidi Crayton, 2014

机译：改用芬戈莫德与坚持服用醋酸格拉替雷或β-干扰素对复发的多发性硬化症患者和医生报告的结果的影响：EPOC试验的事后分析
7. PND6 GLATIRAMER ACETATE VERSUS INTERFERON BETA-1A FOR INTRAMUSCULAR ADMINISTRATION: A COMPARISON OF OUTCOMES AMONG MULTIPLE SCLEROSIS PATIENTS [O] . Castelli-Haley J, Oleen-Burkey M, Lage MJ, 2008

机译：PND6醋酸格拉默对干扰素BETA-1A的肌内给药：多发性硬化症患者治疗效果的比较

PND4 GLATIRAMER ACETATE VERSUS INTERFERON BETA-1B FOR SUBCUTANEOUS ADMINISTRATION: A COMPARISON OF OUTCOMES AMONG MULTIPLE SCLEROSIS PATIENTS

著录项

引文网络

相似文献

相关主题

期刊订阅